Immunopharmacology of tumor necrosis factors α and β
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 7, 388-389
- https://doi.org/10.1016/0165-6147(86)90396-2
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Induction of β2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferationCell, 1986
- Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.The Journal of Experimental Medicine, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature, 1986
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- Tumor Necrosis Factor (TNF)Science, 1985
- Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.The Journal of Experimental Medicine, 1985
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxinNature, 1984
- Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activityNature, 1984